Evidence map›Paper›PMID 32445740›Full record

ReviewThe lancet. Diabetes & endocrinology2020

Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities.

Velandai Srikanth, Alan J Sinclair, Felicia Hill-Briggs, Chris Moran, Geert Jan Biessels

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in The lancet. Diabetes & endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05336942 (Effects of Mild Cognitive Impairment on Auditory System and Its Correlation With Cognitive Function), which is not on this map. Cited by 271 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed, 14 pooled it
28.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05336942 completednot on this map

Effects of Mild Cognitive Impairment on Auditory System and Its Correlation With Cognitive Function: a Multicenter, Randomized Controlled Study

TypeobservationalSponsorTongji UniversityRan2020 to 2022Enrolled90ConditionsMild Cognitive Impairment
3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 14 syntheses or guidelines pooled it, 425 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Velandai SrikanthDepartment of Geriatric Medicine, Peninsula Health, Peninsula Clinical School, Monash University, Melbourne, VIC, Australia. Electronic address: velandai.srikanth@monash.edu.
Alan J SinclairFaculty of Life Sciences and Medicine, King's College London, London, UK.
Felicia Hill-BriggsJohns Hopkins School of Medicine, Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, MD, USA.
Chris MoranDepartment of Geriatric Medicine, Peninsula Health, Peninsula Clinical School, Monash University, Melbourne, VIC, Australia.
Geert Jan BiesselsDepartment of Neurology, UMC Utrecht Brain Center, University Medical Center, Utrecht, Netherlands.
Johns Hopkins University · USKing's College London · GBMonash University · AUPeninsula Health · AUUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes and cognitive dysfunction are highly prevalent disorders worldwide. Although type 2 diabetes is associated with an increased risk of dementia, awareness of the link between the two conditions is poor, and few recommendations are available to guide clinicians about how to approach cognitive dysfunction in people with diabetes. Clinical guidelines in diabetes have only recently begun to emphasise the importance of cognitive impairment in diabetes and its management. This Series paper aims to synthesise knowledge about the link between diabetes and cognitive dysfunction, issues pertaining to screening and diagnosis of cognitive impairment and dementia in those with type 2 diabetes, management of diabetes in people with cognitive dysfunction (accounting for age and frailty), and emerging therapies for prevention. A conceptual framework for approaching screening and diagnosis is included, and future research directions to guide the field forward are suggested.

Indexed as

Disease ManagementCognitive DysfunctionComorbidityDiabetes Mellitus, Type 2HumansTreatment Outcome

Identifiers

PMID32445740
OpenAlexW3028012765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.